Zobrazeno 1 - 10
of 24
pro vyhledávání: '"N P Restifo"'
Autor:
A L Asher, J J Mulé, A Kasid, N P Restifo, J C Salo, C M Reichert, G Jaffe, B Fendly, M Kriegler, S A Rosenberg
Publikováno v:
The Journal of Immunology. 146:3227-3234
Studies of the anti-tumor activity of TNF-alpha in vivo have been hampered by the need to administer systemically toxic doses of the cytokine to obtain a curative response. To facilitate studies of the effect of high local concentrations of TNF-alpha
Autor:
A, van Elsas, R P, Sutmuller, A A, Hurwitz, J, Ziskin, J, Villasenor, J P, Medema, W W, Overwijk, N P, Restifo, C J, Melief, R, Offringa, J P, Allison
Publikováno v:
The Journal of Experimental Medicine
We have previously shown that small B16 melanomas can be successfully treated using a combination of anti-cytotoxic T lymphocyte antigen (CTLA)-4 monoclonal antibody with a granulocyte/macrophage colony-stimulating factor (GM-CSF) producing irradiate
Autor:
Yutaka Kawakami, L. Gattinoni, Chie Kudo-Saito, T. Ishida, N. Sato, N. P. Restifo, Nobuo Tsukamoto, Hiroshi Shiku, L. Chen, R. Ueda, H. Sumimoto, Tomonori Yaguchi
Publikováno v:
International Immunology. 22:ii177-ii178
Autor:
T A, Colella, T N, Bullock, L B, Russell, D W, Mullins, W W, Overwijk, C J, Luckey, R A, Pierce, N P, Restifo, V H, Engelhard
Publikováno v:
The Journal of Experimental Medicine
The human tyrosinase-derived peptide YMDGTMSQV is presented on the surface of human histocompatibility leukocyte antigen (HLA)-A*0201(+) melanomas and has been suggested to be a tumor antigen despite the fact that tyrosinase is also expressed in mela
Publikováno v:
Cancer research. 60(1)
To enhance the immunogenicity of nucleic acid vaccines, we used plasmid DNA vectors that contained replicons derived from the prototype alphavirus, Sindbis, and another alphavirus, Semliki Forest virus. When transfected into cells or injected directl
Autor:
S A, Rosenberg, J C, Yang, D J, Schwartzentruber, P, Hwu, F M, Marincola, S L, Topalian, N P, Restifo, M, Sznol, S L, Schwarz, P J, Spiess, J R, Wunderlich, C A, Seipp, J H, Einhorn, L, Rogers-Freezer, D E, White
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 163(3)
Patients with metastatic melanoma were immunized with an immunodominant peptide derived from the gp100 melanoma-melanocyte differentiation Ag that was modified to increase binding to HLA-A+0201. A total of 10 of 11 patients who received the g209–2M
Autor:
K R, Irvine, M R, Parkhurst, E P, Shulman, J P, Tupesis, M, Custer, C E, Touloukian, P F, Robbins, A G, Yafal, P, Greenhalgh, R P, Sutmuller, R, Offringa, S A, Rosenberg, N P, Restifo
Publikováno v:
Cancer research. 59(11)
To study the induction of anti-"self" CD8+ T-cell reactivity against the tumor antigen gp100, we used a mouse transgenic for a chimeric HLA-A*0201/H-2 Kb molecule (A2/Kb). We immunized the mice with a recombinant vaccinia virus encoding a form of gp1
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 162(6)
CD8+ T lymphocytes that specifically recognize tumor cells can be isolated and expanded ex vivo. While the lytic properties of these cells have been well described, their fate upon encounter with cognate tumor is not known. We performed reverse 51Cr
Publikováno v:
Molecular Approaches to Tumor Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a842f3ddc36f3e16b5a73dc93b25b0
https://doi.org/10.1142/9789812817259_0011
https://doi.org/10.1142/9789812817259_0011
Autor:
S, Gurunathan, K R, Irvine, C Y, Wu, J I, Cohen, E, Thomas, C, Prussin, N P, Restifo, R A, Seder
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(9)
CD40/CD40 ligand interactions have a central role in the induction of both humoral and cellular immunity. In this study, we examined whether a plasmid expressing CD40 ligand/trimer (CD40LT) could enhance immune responses in vivo. BALB/c mice were inj